Cleared Traditional

K171056 - WAVE Clinical Platform

K171056 is an FDA 510(k) clearance for WAVE Clinical Platform, manufactured by Excel Medical Electronics, LLC. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 269-day FDA review.

K171056 · Excel Medical Electronics, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2018
Decision
269d
Days
Class 2
Risk

K171056 is an FDA 510(k) clearance for the WAVE Clinical Platform. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Excel Medical Electronics, LLC (Jupiter, US). The FDA issued a Cleared decision on January 4, 2018 after a review of 269 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Excel Medical Electronics, LLC devices

FDA 510(k) Submission Details - K171056

510(k) Number K171056 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 2017
Decision Date January 04, 2018
Days to Decision 269 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
144d slower than avg
Panel avg: 125d · This submission: 269d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 159
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K171056.
STAR 65
K172147 · Skanray Technologies Pvt, Ltd. · May 2018
PeraServer and PeraTrend
K172959 · Perahealth, Inc. · May 2018
BETTERCARE PLATFORM - ADVANCED WEB CLIENT
K171361 · Better Care, S.L. · Feb 2018
Masimo Root Monitoring System and Accessories
K171121 · Masimo Corporation · Nov 2017
Masimo Rad-97 and Accessories
K170168 · Masimo Corporation · Sep 2017
Unity Network ID
K170199 · Ge Healthcare · May 2017